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Abstract
Owing to a high prevalence of methicillin-resistant Staphylococcus aureus (MRSA) among residents, long-term-care facilities (LTCFs) have
become substantial reservoirs of this microorganism. Few data on the natural history of MRSA colonization in this setting are available.
The cumulative incidence appears to be approximately 20% per year, and more than half of carriers have persistent colonization. Several
host-related factors, such as antibiotic use, invasive devices, and poor infection control practices, increase the risk of colonization. Clini-
cal experience suggests that subsequent MRSA infections are neither frequent nor severe while colonized residents are living in an
LTCF; however, when admitted to an acute-care centre, colonized individuals may spread MRSA to other patients and may develop
severe infections. Therefore, the epidemiological impact of the high prevalence of MRSA in these centres is more relevant than the clin-
ical impact of this colonization for an individual resident. Standard precautions should be applied as routine infection control measures
for all residents of LTCFs, whereas barrier precautions, cohorting, decolonization and other measures should be undertaken only for
controlling outbreaks of MRSA infection.
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Introduction
Over the past two decades, there have been profound
changes in healthcare delivery systems, especially in the USA,
but also in the European Union. The number and size of
acute-care facilities have decreased, as has the number of
admissions, length of stay, and some medical or surgical
activities classically performed in acute-care hospitals. At the
same time, there has been a shift of activities to the outpa-
tient setting, and the magnitude of care delivered at home or
within nursing homes has grown dramatically [1]. Long-term-
care facilities (LTCFs) constitute a heterogeneous group of
institutions that provide care to a large number of patients
with different needs, including those with mental or psychiat-
ric diseases, patients placed for convalescence within nursing
homes, elderly individuals who reside permanently in com-
munity LTCFs, and those who are disabled or ill. Moreover,
patients in LTCFs discharged from acute-care hospitals fre-
quently have invasive devices, and may be colonized with
multiresistant microorganisms, such as methicillin-resistant
Staphylococcus aureus (MRSA), Acinetobacter baumannii, or
extended-spectrum b-lactamase-producing Enterobacteriaceae,
among others [2].
In this new scenario, ‘nosocomial’ infections may occur
not only in acute-care hospitals but also in the other settings
where healthcare is delivered. The term ‘healthcare-associ-
ated infection’ is now commonly used for these infections,
and hospitals are no longer the only healthcare facilities
requiring infection control activities [3].
Although infections in LTCFs are frequent, no extensive
studies on this topic are available in the literature [4].
Host-related factors, such as poor functional status, mental
impairment, alterations in mobility or swallowing, and urinary
incontinence, are especially associated with a higher risk of
developing infections. The most commonly reported infec-
tions are: respiratory infections, often related to aspiration;
urinary tract infections; and skin and soft tissue infections [5].
A major problem related to multiresistant microorganisms is
the spread of MRSA strains. This is true for both acute-care
hospitals and LTCFs—MRSA is endemic in the majority of
both [3,6,7]. Given increasingly common patient exchange
between facilities in the healthcare setting and acute-care
hospitals, it is relevant to determine the magnitude of MRSA
colonization in LTCFs, because it might inﬂuence the infection
control practices implemented by hospitals [8].
Usually, guidelines for the prevention of MRSA transmis-
sion in acute-care hospitals are well established, but there is
often a lack of these recommendations for LTCFs [9].
Among the different proﬁles of LTCFs, this review will focus
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on community LTCFs, which are particular institutions
intended for the promotion of a healthy lifestyle for elderly
people, a steadily-growing segment of the population. Unlike
in acute-care hospitals, discharge of patients from community
LTCFs is not a goal, whereas promoting comfort and an
optimal social environment, and preserving the functional sta-
tus of the residents, are major objectives. Importantly, in
these institutions, ﬁnancial resources for infection control
activities are minimal; the stafﬁng is suboptimal, care is pro-
vided by nurses or by nurse-assistants, and verbal orders,
rather than written orders, are common.
Prevalence and Incidence of MRSA
Colonization in Community LTCFs
The classic studies on the prevalence of MRSA colonization
in LTCFs were performed more than 10 years ago in Veter-
ans’ Affairs (VA) facilities in the USA. These studies showed
a high prevalence of colonization among residents, with rates
ranging from 13% to 35%. Major sites of colonization were
nares and wounds, and, in some institutions, up to 80% of
decubitus ulcers were colonized [10,11]. Although these
studies were of great value, VA institutions are not repre-
sentative of the standard type of community LTCF because,
by deﬁnition, all the residents are male, and usually they are
younger and sicker than the average LTCF resident. Thus,
the epidemiology of MRSA in these facilities should be differ-
entiated from that in community LTCFs [12]. In addition to
US studies, some European studies have recently been per-
formed that have evaluated the prevalence of MRSA coloni-
zation in LTCFs. These studies report prevalences of MRSA
colonization of 22% in the UK [13], 21% in France [14],
16.8% in Spain [15], 9.3% in Slovenia [16], 8.6% in Ireland
[17], and 1.1% in Germany [18]. These ﬁgures are usually
lower than those reported in studies concerning the VA
facilities [10–12,19]. Although these studies generally reﬂect
the endemic situation of MRSA within LTCTs, there is,
remarkably, a wide variation in the prevalence of MRSA col-
onization among community LTCFs. Differences in coloniza-
tion rates may depend on several factors, such as the
prevalence of MRSA in the referral acute-care hospitals, the
characteristics of the resident population, and the quality of
the infection control practices at the LTCF [19].
One study from Germany reported a colonization preva-
lence of 11% during a large outbreak due to a strain of com-
munity-acquired MRSA (CA-MRSA) [20]. To date, the
presence of CA-MRSA in LTCFs has been infrequent; how-
ever, this situation may change in the near future. In a 2004
publication from San Francisco, approximately 4% of CA-
MRSA clinical isolates originated in nursing homes [21], and
a cluster of CA-MRSA infections was noted in ﬁve of 76 resi-
dents in a nursing home in Finland [22].
Persistent carriers are considered to be a group at higher
risk of MRSA transmission, but there are few data on the
relative frequency of persistent vs. transient carriers. In VA
studies, approximately 65% of colonized residents in LTCFs
have persistent MRSA carriage, 25% transient carriage, and
15% intermittent carriage. Similar results have been reported
from community LTCFs in Spain [10,23] (Fig. 1). Recently,
Mody et al. [24] found that more than one-half of community
LTCF residents were colonized by MRSA, often with multi-
ple-site colonization. Extranasal colonization increases signiﬁ-
cantly with the use of invasive devices.
There are few studies addressing the incidence of MRSA
acquisition during a stay in an LTCF. Murder et al. [11]
reported an incidence of approximately 10%. In a longitu-
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FIG. 1. Methicillin-resistant Staphylococcus aureus (MRSA) colonization among residents in long-term-care facilities; relative frequency of persis-
tent vs. transient carriage.
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zation during stays at an LTCF was approximately 20%
[23]. Knowledge of the rate of MRSA acquisition in com-
munity LTCFs is epidemiologically important, and more pro-
spective studies are needed.
Factors Associated with MRSA
Colonization in Community LTCF
Residents
There is general agreement about the risk factors for MRSA
colonization in community LTCF residents. The most impor-
tant are host-related, such as advanced age, poor functional
status, different comorbidities, invasive devices, and decub-
itus ulcers, the last being the most common wound among
residents [10,15]. Some antecedents, including prior MRSA
colonization, prior antibiotic therapy, prior hospitalizations,
and transfer from an acute-care hospital, are also relevant
[13,15,16,25,26]. Finally, speciﬁc characteristics of LTCFs,
such as the size of centre, a low ratio of nurses to beds, and
the location of the facility in a deprived area, have been asso-
ciated with MRSA carriage [13,26,27]. A stay of more than
6 months in an LTCF has been found to be a risk factor for
MRSA colonization [26], but this has not been conﬁrmed in
all studies [17,18].
Clinical Relevance of MRSA Colonization in
Community LTCFs to Development of
MRSA Infections
MRSA-colonized patients have a higher risk of developing
staphylococcal infections than carriers of methicillin-suscepti-
ble S. aureus or non-carriers. In the hospital setting, this risk
has been well described [28,29], but it has been little
explored in LTCFs. However, data indicate that MRSA colo-
nization in LTCFs may have different and less severe conse-
quences than in acute-care hospitals. MRSA carriers have a
30–60% risk of developing an infection during hospitalization
in an acute-care hospital, whereas this risk is only 5–10%
during a stay at an LTCF [19,30]. This difference is probably
best explained by the fact that patients admitted to acute-
care centres undergo more invasive procedures. Few studies
have addressed MRSA infections in different types of LTCFs,
and most have reported a low rate of MRSA infections
among patients in these facilities. Bradley [19] reviewed six
US studies, performed between 1990 and 1997, that
addressed the development of MRSA infections in LTCFs.
Overall, the incidence of infections was 6.5%, the associated
mortality was 1%, and most infections were skin and soft
tissue infections. In one of these studies, Murder et al. [11]
showed that the development of MRSA infections and the
mortality rate were clearly more frequent among MRSA car-
riers, with relative risks of 3.6 and 2, respectively. Most stud-
ies, however, indicate that a relatively small number of
patients require hospitalization or die as a consequence of
MRSA infections, which are usually non-severe. The most
frequently reported MRSA infections among residents in
LTCFs are skin and soft tissue infections, whereas the blood-
stream infection rate is approximately 10% [19,30]. Few lon-
gitudinal studies have been performed to evaluate the risk of
developing MRSA infections among colonized residents in
LTCFs. In a recent prospective study performed in commu-
nity LTCFs in Spain, the incidence of MRSA infections among
MRSA-colonized patients was found to be 0.12/1000 patient-
days. Fifteen episodes of MRSA infection occurred during an
18-month period, mostly skin and soft tissue infections
related to decubitus ulcers, and only two patients required
hospital admission [23].
On the other hand, the admission of MRSA-colonized
residents to an acute-care hospital may have an important
negative impact. Patients from LTCFs and those with re-
admissions to acute-care hospitals account for a large part of
the burden of hospitalized MRSA carriers. Transfer from
LTCFs is a risk factor for having MRSA infection upon admis-
sion to hospital, or for infection during hospitalization [31].
These infections may be severe, with few and expensive
therapeutic options, and elevated morbidity and mortality.
Accordingly, patients transferred from LTCFs should be con-
sidered to be at high risk of MRSA carriage and included in a
screening programme at admission for early MRSA detection
[8,31,32] and rapid implementation of infection control mea-
sures. For this reason, control strategies need to be coordi-
nated between LTCFs and acute-care hospitals.
When MRSA is identiﬁed as the causative microorganism
of infections within a LTCF, the presence of an outbreak
should be ruled out.
Control Measures
The nature of control measures to limit the spread of MRSA in
LTCFs is still controversial [9,33], especially because, for most
residents, the facility is their home. In these institutions, ﬁnan-
cial resources for infection control activities are minimal, the
stafﬁng is suboptimal, and sophisticated diagnostic methods are
lacking. In addition, the clinical impact of MRSA colonization
among residents appears to be limited. Therefore, applying
individualized and easy-to-implement infection control precau-
tions, together with the promotion of a healthy lifestyle for
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residents, is considered to be the best option in a non-epi-
demic setting. Accordingly, standard precautions should be
applied for the care of all patients. Enhanced efforts to prevent
the development of decubitus ulcers is important, given that
they are related to both high rates of MRSA colonization and
infection. It is also very important to avoid non-recommended
measures, especially those that may pose additional difﬁculties
in the transfer of residents between facilities or produce an
increase in the workload of staff. Thus, transfer of patients
from acute-care hospitals to LTCFs should be neither delayed
nor restricted because of MRSA carriage, and detection and
decolonization of residents or healthcare personnel is not nec-
essary unless an MRSA outbreak occurs. The effectiveness of
decolonization with nasal mupirocin has not been demon-
strated among this population, because of the high rate of
recolonization [34]. On the contrary, in identiﬁed outbreaks of
MRSA infection, most authorities recommend the implementa-
tion of contact precautions similar to those applied in acute-
care hospitals [9,19,30].
These recommendations are based on clinical experience
and the limited data existing in the literature (Table 1). The
implementation of each measure should be individually analy-
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Routine measures During an outbreak of MRSA infections
Require screening prior to
transfer to an LTCF
Standard precautions for all patients. Enforce hand
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Refuse or delay admission of
patients known to be infected
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Follow routine, standardized housekeeping practices Screen personnel and residents in contact with infected
patients
Obtain surveillance cultures to
identify MRSA carriers
Register symptomatic MRSA infections Isolate (or remove from duty) those carriers linked to
infected patients
Decolonize of residents or
healthcare personnel
Implement a protocol for MRSA outbreaks Consider the use of nasal mupirocin for carriers
Restrict colonized patients from
common areas or from group
activities
Educational programmes for healthcare staff Consult with public health authorities for advice and
molecular typing
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